|
|
Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| | |
| {{CMG}}; {{AE}} {{EG}} | | {{CMG}}; {{AE}} {{EG}} |
|
| |
|
| <span style="font-size:85%">'''Abbreviations:''' | | <span style="font-size:85%">'''Abbreviations:''' |
| ABG= [[Arterial blood gas]], ANA= [[Antinuclear antibody]], ANP= [[Atrial natriuretic peptide]], ASO= [[Antistreptolysin O|Antistreptolysin O antibody]], BNP= [[Brain natriuretic peptide]], CBC= [[Complete blood count]], COPD= [[Chronic obstructive pulmonary disease]], CRP= [[C-reactive protein]], CT= [[Computed tomography]], CXR= [[Chest X-ray]], DVT= [[Deep vein thrombosis]], ESR= [[Erythrocyte sedimentation rate]], HRCT= [[High Resolution CT]], IgE= [[Immunoglobulin E]], LDH= [[Lactate dehydrogenase]], PCWP= [[Pulmonary capillary wedge pressure]], PCR= [[Polymerase chain reaction]], PFT= [[Pulmonary function test]].</span> | | ABG= [[Arterial blood gas]], ANA= [[Antinuclear antibody]], ANP= [[Atrial natriuretic peptide]], ASO= [[Antistreptolysin O|Antistreptolysin O antibody]], BNP= [[Brain natriuretic peptide]], CBC= [[Complete blood count]], COPD= [[Chronic obstructive pulmonary disease]], CRP= [[C-reactive protein]], CT= [[Computed tomography]], CXR= [[Chest X-ray]], DVT= [[Deep vein thrombosis]], ESR= [[Erythrocyte sedimentation rate]], HRCT= [[High Resolution CT]], IgE= [[Immunoglobulin E]], LDH= [[Lactate dehydrogenase]], PCWP= [[Pulmonary capillary wedge pressure]], PCR= [[Polymerase chain reaction]], PFT= [[Pulmonary function test]].</span> |
| | <small><small> |
| {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" |
| ! colspan="3" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | | ! colspan="3" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases |
Line 35: |
Line 37: |
| ! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Other |
| |- | | |- |
| ! rowspan="30" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Small-Vessel Vasculitis | | ! rowspan="20" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Small-Vessel Vasculitis |
| ! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[ANCA-associated vasculitis]] | | ! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[ANCA-associated vasculitis]] |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Microscopic polyangiitis]]<ref name="pmid20688249">{{cite journal| author=Chung SA, Seo P| title=Microscopic polyangiitis. | journal=Rheum Dis Clin North Am | year= 2010 | volume= 36 | issue= 3 | pages= 545-58 | pmid=20688249 | doi=10.1016/j.rdc.2010.04.003 | pmc=2917831 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20688249 }}</ref> | | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Microscopic polyangiitis]]<ref name="pmid20688249">{{cite journal| author=Chung SA, Seo P| title=Microscopic polyangiitis. | journal=Rheum Dis Clin North Am | year= 2010 | volume= 36 | issue= 3 | pages= 545-58 | pmid=20688249 | doi=10.1016/j.rdc.2010.04.003 | pmc=2917831 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20688249 }}</ref> |
Line 128: |
Line 130: |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Sinusitis]], [[Hemoptysis]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Sinusitis]], [[Hemoptysis]] |
| |- | | |- |
| ! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Immune complexes|Immune complex]] small-vessel vasculitis | | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Immune complexes|Immune complex]] small-vessel vasculitis |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Goodpasture disease|Anti-glomerular basement membrane disease]]<ref name="pmid28515156">{{cite journal |vauthors=McAdoo SP, Pusey CD |title=Anti-Glomerular Basement Membrane Disease |journal=Clin J Am Soc Nephrol |volume=12 |issue=7 |pages=1162–1172 |date=July 2017 |pmid=28515156 |doi=10.2215/CJN.01380217 |url=}}</ref>
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-GBM antibody|Anti-GBM antibodies]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypochromic anemia|Hypochromic microcytic anemia]], [[Thrombocytopenia]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓[[C3 (complement)|C3]] level
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary hemorrhage]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal [[kidneys]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Alveolar]] infiltrates spreading from the [[hilum]] in [[CXR]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Cellular crescents in the [[glomeruli]], [[Pulmonary hemorrhage|Intra-alveolar hemorrhages]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-GBM antibody|Anti-GBM antibodies]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hemoptysis]], [[Hematuria]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cryoglobulinemia|Cryoglobulinemic vasculitis]]<ref name="pmid16344620">{{cite journal |vauthors=Ferri C, Mascia MT |title=Cryoglobulinemic vasculitis |journal=Curr Opin Rheumatol |volume=18 |issue=1 |pages=54–63 |date=January 2006 |pmid=16344620 |doi= |url=}}</ref>
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C4A|C4 component]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Anemia]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antinuclear antibodies|ANA]], [[hypocomplementemia]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |R/O underlying [[malignancy]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stenosis]] or [[Occlusion|occlusions]] of the [[Visceral|visceral arteries]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bacterial endocarditis]] in [[echocardiography]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Interstitial]] involvement or [[pleural effusions]] in [[CXR]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HCV]]-associated [[proteins]] in [[vasculitic]] [[skin]], Intraluminal [[cryoglobulin]] deposits
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acrocyanosis]], [[Retinal]] [[hemorrhage]], [[Purpura]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]]<ref name="pmid28810602">{{cite journal| author=Guo QY, Wu M, Wang YW, Sun GD| title=Hepatitis C virus-associated cryoglobulinemia with membrano-proliferative glomerulonephritis treated with prednisolone and interferon: A case report. | journal=Exp Ther Med | year= 2017 | volume= 14 | issue= 2 | pages= 1395-1398 | pmid=28810602 | doi=10.3892/etm.2017.4671 | pmc=5525644 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28810602 }}</ref> | | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C virus]]-associated [[Cryoglobulinemia|cryoglobulinemic vasculitis]]<ref name="pmid28810602">{{cite journal| author=Guo QY, Wu M, Wang YW, Sun GD| title=Hepatitis C virus-associated cryoglobulinemia with membrano-proliferative glomerulonephritis treated with prednisolone and interferon: A case report. | journal=Exp Ther Med | year= 2017 | volume= 14 | issue= 2 | pages= 1395-1398 | pmid=28810602 | doi=10.3892/etm.2017.4671 | pmc=5525644 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28810602 }}</ref> |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- |
Line 191: |
Line 151: |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatitis C|HCV RNA]], [[Histopathology|Histological confirmation]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatitis C|HCV RNA]], [[Histopathology|Histological confirmation]] |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Palpable [[purpura]], [[Microscopic hematuria]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Palpable [[purpura]], [[Microscopic hematuria]] |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Henoch-Schönlein purpura|IgA vasculitis (Henoch-Schönlein purpura)]]<ref name="pmid26990342">{{cite journal |vauthors=Farhadian JA, Castilla C, Shvartsbeyn M, Meehan SA, Neimann A, Pomeranz MK |title=IgA vasculitis (Henoch-Schönlein purpura) |journal=Dermatol. Online J. |volume=21 |issue=12 |pages= |date=December 2015 |pmid=26990342 |doi= |url=}}</ref>
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[IgA]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Normochromic anemia]], [[Leukocytosis]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Occult blood|Stool OB]], ↓[[C3 (complement)|C3]], ↓[[C4A|C4]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased [[bowel]] wall thickness, [[Hematoma|hematomas]], [[peritoneal fluid]], and [[intussusception]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Dilated loops of [[bowel]] consistent in [[abdominal X-ray]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytoclastic vasculitis]] in postcapillary [[venules]] with [[IgA]] deposition
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |History and [[physical examination]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]], [[Purpura|Palpable purpura]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hypocomplementemia|Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis)]]<ref name="pmid22328958">{{cite journal| author=Buck A, Christensen J, McCarty M| title=Hypocomplementemic urticarial vasculitis syndrome: a case report and literature review. | journal=J Clin Aesthet Dermatol | year= 2012 | volume= 5 | issue= 1 | pages= 36-46 | pmid=22328958 | doi= | pmc=3277093 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22328958 }}</ref>
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[C11orf1|C1q]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mild [[anemia]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antinuclear antibodies|ANA]], ↓[[C10orf10|C1q]], ↓[[C3 (complement)|C3]], ↓[[C4A|C4]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatomegaly]], [[Splenomegaly]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Deposits of [[immunoglobulins]], [[complement]], or [[fibrin]] around [[blood vessels]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Urticaria]],
| |
|
| |
| [[Histopathology|Histological confirmation]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Urticaria]], [[Hematuria]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Gastrointestinal diseases|Gastrointestinal disease]]
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Acute mesenteric ischemia]]<ref name="pmid24267504">{{cite journal |vauthors=Sise MJ |title=Acute mesenteric ischemia |journal=Surg. Clin. North Am. |volume=94 |issue=1 |pages=165–81 |date=February 2014 |pmid=24267504 |doi=10.1016/j.suc.2013.10.012 |url=}}</ref>
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[FABP1|I-FABP]], [[GSTA1|Alpha-GST]], [[Ischemia-modified albumin (IMA)]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], ↑[[Hematocrit|HCT]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↑[[Amylase]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bowel]] wall thickening, [[Pneumatosis intestinalis|Intestinal pneumatosis]], [[Mesenteric ischemia|Portomesenteric]] thrombosis
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Mesenteric vein thrombosis|Mesenteric venous thrombosis]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Artery|Arterial]] [[stenosis]] or occlusion of the [[Celiac artery|celiac]] or [[superior mesenteric arteries]] in [[duplex ultrasound]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ileus]] with distended loops of [[bowel]], [[Bowel]] wall thickening in [[abdominal X-ray]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Superficial [[Mucosal bleeding|mucosal hemorrhage]], [[edema]] and [[necrosis]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |History and [[physical examination]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Abdominal pain]], [[Distension]], [[Absent bowel sounds]]
| |
| |- | | |- |
| ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular diseases|Cardiovascular disease]] | | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular diseases|Cardiovascular disease]] |
Line 301: |
Line 195: |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Purpura|Palpable purpura]], [[Petechiae]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Purpura|Palpable purpura]], [[Petechiae]] |
| |- | | |- |
| ! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary disease]] | | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary disease]] |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Langerhans Cell Histiocytosis]]<ref name="pmid18572052">{{cite journal |vauthors=Margo CE, Goldman DR |title=Langerhans cell histiocytosis |journal=Surv Ophthalmol |volume=53 |issue=4 |pages=332–58 |date=2008 |pmid=18572052 |doi=10.1016/j.survophthal.2008.04.007 |url=}}</ref>
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[CD1a]], CD207,[[BRAF (gene)|BRAF-V600E]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypercalcemia]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary cystic lymphangiectasis|Pulmonary cysts]] and [[Pulmonary nodule|nodules]], [[Lytic|Bone lytic lesions]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatomegaly]], [[Splenomegaly]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cerebellum]] and [[pons]] hyperintensity in [[MRI]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Birbeck granules]] by [[electron microscopy]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology|Histological confirmation]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Brown to purplish [[papules]], [[Eczematous Scaling|Eczematous rash]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non small cell lung cancer|Non-Small Cell Lung Cancer]]<ref name="pmid18452692">{{cite journal| author=Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA| title=Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. | journal=Mayo Clin Proc | year= 2008 | volume= 83 | issue= 5 | pages= 584-94 | pmid=18452692 | doi=10.4065/83.5.584 | pmc=2718421 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18452692 }}</ref> | | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non small cell lung cancer|Non-Small Cell Lung Cancer]]<ref name="pmid18452692">{{cite journal| author=Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA| title=Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. | journal=Mayo Clin Proc | year= 2008 | volume= 83 | issue= 5 | pages= 584-94 | pmid=18452692 | doi=10.4065/83.5.584 | pmc=2718421 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18452692 }}</ref> |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- |
Line 363: |
Line 236: |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Spindled cells with dark [[nuclei]], scant [[cytoplasm]], and fine, granular [[Chromatin|nuclear chromatin]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Spindled cells with dark [[nuclei]], scant [[cytoplasm]], and fine, granular [[Chromatin|nuclear chromatin]] |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Computed tomography|High resolution CT-scan]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Computed tomography|High resolution CT-scan]] |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cough]], [[Hemoptysis]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pulmonary Infarction]]<ref name="pmid15821192">{{cite journal |vauthors=Parambil JG, Savci CD, Tazelaar HD, Ryu JH |title=Causes and presenting features of pulmonary infarctions in 43 cases identified by surgical lung biopsy |journal=Chest |volume=127 |issue=4 |pages=1178–83 |date=April 2005 |pmid=15821192 |doi=10.1378/chest.127.4.1178 |url=}}</ref>
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[D-dimer]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mild [[leukocytosis]], Mild [[anemia]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hypoxemia]], [[Hypocarbia]] or [[Hypercarbia]], [[Respiratory alkalosis]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary embolism]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low-[[density]] filling defect within the [[pulmonary artery]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pericardial effusion]] in [[echocardiography]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary]] infiltrates, [[atelectasis]], and [[pleural effusions]] in [[Chest X-ray|CXR]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Infarct]] induced [[apoptosis]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pulmonary artery]] [[angiography]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cough]], [[Hemoptysis]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cough]], [[Hemoptysis]] |
| |- | | |- |
Line 408: |
Line 260: |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]] |
| |- | | |- |
| ! rowspan="8" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hematologic disease]] | | ! rowspan="7" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hematologic disease]] |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hemolytic-uremic syndrome|Hemolytic-Uremic Syndrome]]<ref name="pmid11691946">{{cite journal |vauthors=Corrigan JJ, Boineau FG |title=Hemolytic-uremic syndrome |journal=Pediatr Rev |volume=22 |issue=11 |pages=365–9 |date=November 2001 |pmid=11691946 |doi= |url=}}</ref> | | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hemolytic-uremic syndrome|Hemolytic-Uremic Syndrome]]<ref name="pmid11691946">{{cite journal |vauthors=Corrigan JJ, Boineau FG |title=Hemolytic-uremic syndrome |journal=Pediatr Rev |volume=22 |issue=11 |pages=365–9 |date=November 2001 |pmid=11691946 |doi= |url=}}</ref> |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ |
Line 471: |
Line 323: |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Protein electrophoresis]] plus conventional [[X-rays]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Protein electrophoresis]] plus conventional [[X-rays]] |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Constipation]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Constipation]] |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hypereosinophilic syndrome|Hypereosinophilic Syndrome]]<ref name="pmid19630574">{{cite journal |vauthors=Klion A |title=Hypereosinophilic syndrome: current approach to diagnosis and treatment |journal=Annu. Rev. Med. |volume=60 |issue= |pages=293–306 |date=2009 |pmid=19630574 |doi=10.1146/annurev.med.60.062107.090340 |url=}}</ref>
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[IgE]], [[CD117]] with [[CD2]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Eosinophilia]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑Serum [[tryptase]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Lymphadenopathy]] and [[splenomegaly]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Intracardiac thrombus|Intracardiac thrombi]] in [[echocardiography]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Reticulin|Reticulin stain]] for [[myelofibrosis]] and [[tryptase]] staining for [[mast cells]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with [[Medical laboratory|laboratory abnormalities]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Splinter hemorrhages]], [[Raynaud phenomenon]]
| |
| |- | | |- |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non-Hodgkin lymphoma|Non-Hodgkin Lymphoma]]<ref name="pmid22835603">{{cite journal |vauthors=Shankland KR, Armitage JO, Hancock BW |title=Non-Hodgkin lymphoma |journal=Lancet |volume=380 |issue=9844 |pages=848–57 |date=September 2012 |pmid=22835603 |doi=10.1016/S0140-6736(12)60605-9 |url=}}</ref> | | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Non-Hodgkin lymphoma|Non-Hodgkin Lymphoma]]<ref name="pmid22835603">{{cite journal |vauthors=Shankland KR, Armitage JO, Hancock BW |title=Non-Hodgkin lymphoma |journal=Lancet |volume=380 |issue=9844 |pages=848–57 |date=September 2012 |pmid=22835603 |doi=10.1016/S0140-6736(12)60605-9 |url=}}</ref> |
Line 577: |
Line 408: |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Easy bruising]], [[Purpura]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Easy bruising]], [[Purpura]] |
| |- | | |- |
| ! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]] | | ! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]] |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Sarcoidosis]]<ref name="pmid27454074">{{cite journal| author=Chiarchiaro J, Chen BB, Gibson KF| title=New molecular targets for the treatment of sarcoidosis. | journal=Curr Opin Pulm Med | year= 2016 | volume= 22 | issue= 5 | pages= 515-21 | pmid=27454074 | doi=10.1097/MCP.0000000000000304 | pmc=5152532 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27454074 }}</ref> | | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Sarcoidosis]]<ref name="pmid27454074">{{cite journal| author=Chiarchiaro J, Chen BB, Gibson KF| title=New molecular targets for the treatment of sarcoidosis. | journal=Curr Opin Pulm Med | year= 2016 | volume= 22 | issue= 5 | pages= 515-21 | pmid=27454074 | doi=10.1097/MCP.0000000000000304 | pmc=5152532 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27454074 }}</ref> |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ |
Line 641: |
Line 472: |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-dsDNA antibody|Anti-dsDNA antibody test]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-dsDNA antibody|Anti-dsDNA antibody test]] |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Skin rashes]] or [[photosensitivity]] | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Skin rashes]] or [[photosensitivity]] |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Rheumatoid arthritis]]<ref name="pmid16824912">{{cite journal| author=Scott JT| title=The gold standard in rheumatoid arthritis. | journal=J R Soc Med | year= 1991 | volume= 84 | issue= 9 | pages= 513-4 | pmid=1682491 | doi= | pmc=1293405 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1682491 }}</ref>
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[RF]], [[Anti-citrullinated protein antibody|Anti-CCP antibody]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]],
| |
| ↑[[ALT]] or [[AST]], [[ANA]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Fractures|Microfractures]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aneurysms]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Joint (anatomy)|Effusions in joints]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Basilar invagination with [[cranial]] migration of an eroded [[Odontoid process|odontoid]] peg in [[MRI]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Influx of [[inflammatory cells]] into the [[synovial membrane]], with [[angiogenesis]], proliferation of chronic [[inflammatory cells]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled [[Anti-citrullinated protein antibody|anti-CCP antibody]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Rheumatoid nodules]]
| |
| |-
| |
| ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Relapsing polychondritis]]<ref name="pmid27708954">{{cite journal| author=Emmungil H, Aydın SZ| title=Relapsing polychondritis. | journal=Eur J Rheumatol | year= 2015 | volume= 2 | issue= 4 | pages= 155-159 | pmid=27708954 | doi=10.5152/eurjrheum.2015.0036 | pmc=5047229 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27708954 }}</ref>
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Anemia]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |-
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cryoglobulins]], [[ANA]], [[C-ANCA]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Calcification]] of [[Cartilaginous|cartilaginous structures]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aortic root|Aortic root dilatation]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aortic root|Aortic root dilatation]] and degree of [[aortic regurgitation]] in [[echocardiography]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Tracheal stenosis]] in [[CXR]]
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Chondrolysis, [[Chondritis]], Perichondritis
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical findings coupled with imaging
| |
| ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ear pain]] and redness, [[Polyarthritis]]
| |
| |- | | |- |
| |} | | |} |
| | | </small></small> |
| ==References== | | ==References== |
| {{Reflist|2}} | | {{Reflist|2}} |